Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Faculty of Science, Charles University
- Leiden University
- University of Nottingham
- University of Porto
- Friedrich Schiller University Jena •
- KU LEUVEN
- The University of Manchester
- Uppsala universitet
- Wetsus - European centre of excellence for sustainable water technology
- Academic Europe
- ETH Zürich
- Erasmus University Rotterdam
- Faculdade de Ciências e Tecnologia
- Faculdade de Medicina da Universidade do Porto
- Forschungszentrum Jülich
- Friedrich Schiller University Jena
- IFP Energies nouvelles (IFPEN)
- INSERM 1116
- Institute of Physical Chemistry, Polish Academy of Sciences
- Instituto Português de Oncologia Francisco Gentil, EPE
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- King's College London
- Ludwig-Maximilians-Universität München •
- Nature Careers
- Philipps University Marburg
- Purdue University
- Radboud University Medical Center (Radboudumc)
- Stockholms universitet
- Technical University of Denmark
- The University of Iowa
- Ulm University •
- Universidade de Coimbra
- University of Beira Interior
- University of Bergen
- University of British Columbia
- University of Oslo
- University of Santiago de Compostela
- University of Southern Denmark
- University of Sussex
- Université Claude Bernard Lyon 1
- Vrije Universiteit Brussel (VUB)
- 31 more »
- « less
-
Field
-
, functionalization of electrode surfaces for catalytic applications, additive manufacturing of pharmaceutical materials, microsensors for in vivo usage and sustainable materials from biomass. Researchers here thus
-
and deadlines, please visit: http://www.jsmc.uni-jena.de . Tuition fees per semester in EUR None Combined Master's degree / PhD programme No Joint degree / double degree programme No Description/content
-
strategic decisions when technologies are complex, development timelines are long, and uncertainty is high? We invite PhD candidates to explore these questions in the context of the pharmaceutical and
-
cardiovascular disease, chronic kidney disease, cancer and chronic inflammatory disease. For more information: https://www.cordis.europa.eu/project/id/101225380 Cardiovascular disease (CVD) is the leading cause
-
development, both in academic and commercial settings, whether it is a position requiring processing and analysis of biomolecular data (e.g., in hospitals) or research positions in the pharmaceutical industry
-
institutes, in education sector, health care or veterinary medicine, but also in state/governmental administration or in private (e.g., pharmaceutical or biotechnology companies), both in the Czech
-
biology and bioinformatics. It intersects with most biological areas and highly impacts modern medicine and the development of new biotechnologies with applications in food and pharmaceutic industry
-
/governmental administration or in private (e.g., pharmaceutical or biotechnology companies), both in the Czech Republic and abroad. Application submission The application is submitted electronically through
-
both basic or applied research at universities, in scientific institutes and biotechnological centres as well as in medical institutions and pharmaceutical industry. Application submission
-
gain a robust, comprehensive toolkit and interdisciplinary expertise essential for a professional career in the modern pharmaceutical industry or academic structural biology. For enquiries about the